- Exchange: EN Paris
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
NicOx SA+ Add to Watchlist
COX:FP1.9890 EUR 0.1550 7.23%
As of 11:35:00 ET on 03/06/2015.
Company Profile for NicOx SA (COX)
NicOx develops pharmaceuticals using recently discovered properties of nitric oxide. The Company develops drugs-candidates for the potential treatment of inflammatory, cardiometabolic and ophthalmological diseases. NicOx's lead compound naproxcinod is developed for the relief of the signs and symptoms of osteoarthritis.
Key Executives for NicOx SA (COX)
|Michele GarufiChairman/CEO/Co-Founder||Evelyne NguyenChief Financial Officer|
|Michael BergaminiExec VP/Chief Scientific Ofcr||Philippe MasquidaExec VP/Mng Dir:European & Intl Ops|
|Gavin SpencerExec VP:Corporate Development||Davide BuffoniManaging Director:Spain|
|Benito GuerraManaging Director:Italy||Torsten CorneliusManaging Director:Germany|
|Jean-Francois MazelierManaging Director:France|